The biopharmaceutical industry is grappling with a profound challenge: the silent erosion of critical process knowledge, particularly "tacit knowledge," during…
Read More
New Therapies Usher in Era of Personalised Treatment for Rare Blood Cancers
A significant advancement in the treatment of rare blood cancers is set to transform the lives of approximately 200 patients…
Read More
Molecular Switch Discovery Enhances Blood Stem Cell Activation for Advanced Bone Marrow Transplants and Gene Therapies
A breakthrough preclinical study led by investigators at Weill Cornell Medicine has identified a singular molecular switch, known as FLI-1,…
Read More
As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
The pharmaceutical industry, particularly the rapidly evolving biopharmaceutical sector, faces a silent but significant challenge: the erosion of critical "tacit…
Read More
As Cell Therapies Scale and CDMOs Cut Staff, Process Know-How Is Often Getting Lost in Tech Transfer
The biopharmaceutical industry is grappling with a critical challenge: the silent erosion of invaluable "tacit knowledge" during technology transfer processes.…
Read More
Unlocking Nature’s Pharmacy: Scientists Decipher Bacterial Secrets to Multi-Drug Cancer Therapies
For decades, the intricate molecular dance within bacteria that yields a remarkable array of potent anti-cancer compounds remained an enigma,…
Read More
Pioneering Immune-Based Therapies: How NK Cell-Derived Extracellular Vesicles Offer New Hope for Traumatic Brain Injury and Alzheimer’s Disease
Traumatic brain injury (TBI) stands as a formidable global health crisis, impacting an estimated 69 million individuals each year with…
Read More
Navigating the Knowledge Gap: How Workforce Shifts and Advanced Therapies Threaten Biopharma’s Critical Tech Transfer Process
The intricate world of biopharmaceutical manufacturing is currently grappling with a silent, yet profoundly impactful, challenge: the erosion of tacit…
Read More
Molecular Switch Discovery Enhances Blood Stem Cell Activation for Improved Bone Marrow Transplants and Gene Therapies
In a landmark preclinical study that promises to redefine the landscape of regenerative medicine, investigators at Weill Cornell Medicine have…
Read More
As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
The biopharmaceutical industry, in its relentless pursuit of innovation and efficiency, faces a silent but profound challenge: the erosion of…
Read MoreYOU MAY HAVE MISSED
